| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/02/2003 | EP1323710A1 Nitrogenous five-membered ring compounds |
| 07/02/2003 | EP1323425A1 Composition for diminishing neutral fat in blood |
| 07/02/2003 | EP1322954A1 Method for treatment of insulin resistance in obesity and diabetes |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322760A2 G-protein coupled receptors |
| 07/02/2003 | EP1322755A1 Human and mouse targeting peptides identified by phage display |
| 07/02/2003 | EP1322752A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 07/02/2003 | EP1322673A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 07/02/2003 | EP1322647A1 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt and process for their preparation |
| 07/02/2003 | EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai |
| 07/02/2003 | EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 07/02/2003 | EP1322623A2 Hydroxy acid integrin antagonists |
| 07/02/2003 | EP1322621A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 07/02/2003 | EP1322620A1 Benzimidazole and indole derivatives as crf receptor modulators |
| 07/02/2003 | EP1322617A1 Compounds and methods for modulation of estrogen receptors |
| 07/02/2003 | EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 07/02/2003 | EP1322336A1 Method of increasing testosterone and related steroid concentrations in women |
| 07/02/2003 | EP1322315A1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 07/02/2003 | EP1322314A2 Treatment of diabetes mellitus by inhibition of mitochondrial calcium/sodium antiporter |
| 07/02/2003 | EP1322310A1 Alpha v integrin receptor antagonists |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | EP1322306A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 07/02/2003 | EP1322300A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 07/02/2003 | EP1322298A1 Pharmaceutical oxan preparation |
| 07/02/2003 | EP1322296A1 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 07/02/2003 | EP1322289A1 Spray drying process and compositions of fenofibrate |
| 07/02/2003 | EP1322182A2 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof |
| 07/02/2003 | EP1322176A1 Use of carnitine for enhancing training-induced bradycardia |
| 07/02/2003 | EP1322175A2 Food supplement |
| 07/02/2003 | EP1322158A1 Sustained release pharmaceutical compositions containing metformin and method of its production |
| 07/02/2003 | EP1239885A4 Interventions to mimic the effects of calorie restriction |
| 07/02/2003 | EP1224180B1 Substituted azoles |
| 07/02/2003 | EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 07/02/2003 | EP1140861B1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 07/02/2003 | EP1073694B1 Trans-xanthophyll ester concentrates of enhanced purity and methods of making same |
| 07/02/2003 | EP0801557B1 Liposome formulations of 5beta steroids |
| 07/02/2003 | EP0782986B1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/02/2003 | EP0781129B1 Pharmaceutical preparation containing metformin and a process for producing it |
| 07/02/2003 | EP0779810B1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 07/02/2003 | EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 07/02/2003 | CN1427952A Docosahexaenoic acid as retinoid X receptor and uses thereof |
| 07/02/2003 | CN1427889A Hybrid cells obtainable from antigen presenting cells |
| 07/02/2003 | CN1427845A Cyclipostins, method for their production and use of same |
| 07/02/2003 | CN1427838A Hydantoin-containing glucokinase activators |
| 07/02/2003 | CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments |
| 07/02/2003 | CN1427833A Method for production of L-ascorbic acid by lactonisation of 2-keto-L-gulonic acid or 2-keto-L-gulonate esters |
| 07/02/2003 | CN1427830A Para-substituted phenylamide glucokinase activators |
| 07/02/2003 | CN1427829A Substituted phenylacetamides and their use as glucokinase activators |
| 07/02/2003 | CN1427826A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use |
| 07/02/2003 | CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 07/02/2003 | CN1427730A Medicinal aerosol formulation |
| 07/02/2003 | CN1427726A Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 07/02/2003 | CN1427725A Casein derived peptides and uses thereof in therapy |
| 07/02/2003 | CN1426812A Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma |
| 07/02/2003 | CN1426807A Health care food capable of assisting combustion and decomposing excess fat to reduce body weight |
| 07/02/2003 | CN1426806A Health care food capable of eliminating honeycomb fat |
| 07/02/2003 | CN1426804A Health care food for reducing body weight due to excess fat in meal |
| 07/02/2003 | CN1426796A Natural nutritive liquid |
| 07/02/2003 | CN1426780A Gel type slow release tablet for treating diabetes and its preparation method |
| 07/02/2003 | CN1426702A Health care food for maintaining intestinal health and assisting to reduce abdomen fat |
| 07/02/2003 | CN1113102C Antitumer preparation |
| 07/02/2003 | CN1113057C Quinoline derivatives |
| 07/02/2003 | CN1112926C Composition comprising 5-[4-(2-(n-methyl-N-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 07/01/2003 | US6586582 Human GABA receptor proteins and polynucleotides encoding the same |
| 07/01/2003 | US6586474 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586467 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus |
| 07/01/2003 | US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide |
| 07/01/2003 | US6586448 Cholesteryl ester transfer protein inhibitors used as antilipemic agents for prophylaxis of cardiovascular disorders |
| 07/01/2003 | US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea |
| 07/01/2003 | US6586438 Low dose combination of metformin and another antidiabetic agent such as glyburide; side effect reduction; for first line therapy in treating diabetes |
| 07/01/2003 | US6586434 Method for the preparation of tetrahydrobenzothiepines |
| 07/01/2003 | US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders |
| 07/01/2003 | US6586421 For therapy of central nervous system, including diseases, disorders, and conditions related to, such as anxiety, depression, hypertension, migraine, obesity, compulsive disorders, schizophrenia, autism, neurodegenerative disorders |
| 07/01/2003 | US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a |
| 07/01/2003 | US6586179 Human Eag2 |
| 07/01/2003 | US6585995 Administering to a subject to inhibit a vaso-occlusive event an agent that reduces platelet counts in the subject in an amount effective to reduce platelet count in the subject to at least a low normal level |
| 07/01/2003 | US6585971 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof |
| 07/01/2003 | CA2089194C Steroid derivatives |
| 06/26/2003 | WO2003052124A2 Screening method for agents useful in treating diabetes |
| 06/26/2003 | WO2003052106A1 Method of screening compounds |
| 06/26/2003 | WO2003052048A2 Nucleic acid-associated proteins |
| 06/26/2003 | WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 06/26/2003 | WO2003051911A2 Gmg-5 polynucleotides and polypeptides and uses thereof |
| 06/26/2003 | WO2003051893A2 Improvements in pharmaceutical compositions |
| 06/26/2003 | WO2003051890A1 Imidazo [2,1-b]-1,3,4-thiadiazole suflonamides |
| 06/26/2003 | WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 06/26/2003 | WO2003051887A1 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors |
| 06/26/2003 | WO2003051878A1 Quinolinones as prostaglandin receptor ligands |
| 06/26/2003 | WO2003051872A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 06/26/2003 | WO2003051871A1 N-aroyl cyclic amine derivatives and their use as orxin receptor antagonist |
| 06/26/2003 | WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 06/26/2003 | WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS |
| 06/26/2003 | WO2003051859A1 Compounds for imaging alzheimer's disease |
| 06/26/2003 | WO2003051851A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 06/26/2003 | WO2003051847A1 (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors |
| 06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |